NHS Framework for the NHS London Region, Branded Medicines - Tranche A
Details
- Buyer
- NHS England
- Supplier(s)
28 suppliers
- Abbvie Ltd
- Accord UK Ltd
- Allergan Limited
- Amgen Ltd
- Biogen Idec Ltd
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Celltrion Healthcare United Kingdom Ltd
- Eli Lilly and Company Ltd
- Ferring Pharmaceutical
- Gilead Sciences Ltd, 280 High Holborn
- Ipsen Ltd
- Janssen Cilag Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Merz
- Napp Pharmaceuticals Ltd
- Novartis Pharmaceutical UK Ltd
- Novo Nordisk Ltd
- Pfizer Liimted
- Pharmacosmos UK Ltd
- Roche Products Ltd
- Sandoz
- Takeda UK Limited
- Teva UK Ltd
- Thornton and Ross
- UCB Pharma Ltd
- Vifor Pharma UK Ltd
- ViiV Healthcare
- Value
- GBP 191,062,951
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 15 September 2020
- Source
- uk:contracts_finder
Tender description
NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine Offer reference number: CM/PHR/16/5516 CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5516/03 - NHS Framework agreement for the supply of Dolutegravir / Lamivudine - North of England - 1 September 2020 - 28 February 2021, South of England - 1 September 2020 - 31 August 2021, Midlands & East - 1 September 2020 - 28 February 2022, all with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Timeline
- Completed: Award date1 September 2020
- Completed: Award published15 September 2020Current notice
- Completed: Contract expiry date31 August 2022
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework for the NHS London Region, Branded Medicines - Tranche A.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 357£15.0bn
- 293£2.8bn
- 263£19.7bn
- 253£892.5m
- 246£509.3m
- 203£1.0bn
- 140£895.5m
- 115£59.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
